Emerald Health Therapeutics Signs Arrangement Agreement with Skye Bioscience
Arrangement is expected to fund Skye's proprietary synthetic cannabinoid-derivative therapeutic initially targeting glaucoma for first Phase 2 clinical study planned to...
Day: May 12, 2022
Nova Mentis Welcomes Autism Behaviour Analyst to its Science Team
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)...
NervGen Pharma Receives Approval to Proceed to the Final Dose Cohort in Phase 1 Clinical Trial of NVG-291 and Reports Q1 2022 Results
Safety Review Committee approves proceeding to third and highest dose cohort in multiple ascending dose portion of clinical trial No...
Halberd Submits Audited Financials; Files Form-10 as First Step to Up-List to OTCQB
Jackson Center, Pennsylvania--(Newsfile Corp. - May 12, 2022) - Halberd Corporation (OTC Pink: HALB) submitted its fully audited financials through...
Hospital IQ Wins Best Predictive Analytics Solution in 2022 MedTech Breakthrough Awards
Recognition marks third consecutive year Hospital IQ has been named MedTech Breakthrough winner NEWTON, Mass.--(BUSINESS WIRE)--Hospital IQ, a leading intelligent...
Panacea Life Sciences Adds Vegan Softgel Manufacturing Capabilities to Meet the Growing Demand for Clean, Natural Alternatives to Animal Derivatives
GOLDEN, CO / ACCESSWIRE / May 12, 2022 / Panacea Life Sciences, Inc. (OTCQB:PLSH), ("Panacea" or the "Company"), a Colorado,...
Occlutech Progress in US – First Patient has been Enrolled in Important US FDA Study
SCHAFFHAUSEN, CH / ACCESSWIRE / May 12, 2022 / Occlutech Holding AGOcclutech Holding AG ("Occlutech"), one of the world's leading...
Biophytis: Biophytis Announces its Participation at the BIO International Convention in San Diego from the 13th to the 16th of June
PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / May 12, 2022 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis" or...
Reimbursement Established for Lung and Liver Transplant in the Netherlands Based on Results from Clinical Trials with XVIVO’s Leading Technologies
GOTHENBURG, SE / ACCESSWIRE / May 12, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)Machine perfusion for lungs and livers...
Poolbeg Pharma PLC – GMP Manufacturing Contract Signed
Update on POLB 001 Clinical Development GMP manufacturing contract signed ensuring ample supply of POLB 001 for clinical development and...
Spexis to Present at BioEquity Europe 2022
ALLSHWIL, SWITZERLAND / ACCESSWIRE / May 12, 2022 / Spexis AG (SIX: SPEX) today announced that that the company will...